A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

被引:32
|
作者
Lindstroem, Sara [2 ,3 ]
Ma, Jing [6 ]
Altshuler, David [7 ,8 ,9 ,10 ,11 ]
Giovannucci, Edward [4 ]
Riboli, Elio [12 ]
Albanes, Demetrius [13 ]
Allen, Naomi E. [14 ]
Berndt, Sonja I. [13 ]
Boeing, Heiner [15 ]
Bueno-de-Mesquita, H. Bas [16 ]
Chanock, Stephen J. [13 ]
Dunning, Alison M. [17 ]
Feigelson, Heather Spencer [18 ,19 ]
Gaziano, J. Michael [20 ,21 ,22 ]
Haiman, Christopher A. [23 ]
Hayes, Richard B. [13 ,24 ]
Henderson, Brian E. [23 ]
Hunter, David J. [2 ,6 ]
Kaaks, Rudolf [25 ]
Kolonel, Laurence N. [26 ]
Le Marchand, Loic [26 ]
Martinez, Carmen [27 ,28 ]
Overvad, Kim [29 ]
Siddiq, Afshan [12 ]
Stampfer, Meir [3 ,4 ,6 ]
Stattin, Paer [30 ]
Stram, Daniel O. [23 ]
Thun, Michael J. [18 ]
Trichopoulos, Dimitrios [3 ]
Tumino, Rosario [31 ]
Virtamo, Jarmo [32 ]
Weinstein, Stephanie J. [13 ]
Yeager, Meredith [33 ]
Kraft, Peter [2 ,3 ,5 ]
Freedman, Matthew L. [1 ,34 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA
[7] Broad Inst Massachusetts Inst Technol MIT & Harva, Program Med & Populat Genet, Cambridge, MA USA
[8] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA
[9] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA
[10] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA
[11] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA
[12] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London, England
[13] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[14] Univ Oxford, Canc Epidemiol Unit, Oxford, England
[15] German Inst Human Nutr Potsdam Rehbrucke, Nuthetal, Germany
[16] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
[17] Univ Cambridge, Dept Oncol, Cambridge, England
[18] Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA
[19] Kaiser Permanente, Denver, CO USA
[20] Boston Vet Affairs Healthcare Syst, Massachusetts Vet Epidemiol & Res Informat Ctr, Boston, MA USA
[21] Boston Vet Affairs Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA
[22] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02115 USA
[23] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
[24] NYU, Div Epidemiol, Langone Med Ctr, New York, NY USA
[25] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany
[26] Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA
[27] Ctr Invest Biomed Red Epidemiol & Salud Publ, Granada, Spain
[28] Andalusian Sch Publ Hlth, Granada, Spain
[29] Aarhus Univ Hosp, Aalborg Hosp, Aalborg, Denmark
[30] Umea Univ, Umea, Sweden
[31] Canc Registry Azienda Osped Civile MP Arezzo, Ragusa, Italy
[32] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland
[33] NCI, Core Genotyping Facil, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA
[34] Broad Inst Harvard & MIT, Cambridge, MA USA
来源
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2010年 / 95卷 / 09期
基金
美国国家卫生研究院; 瑞典研究理事会;
关键词
CAG-REPEAT POLYMORPHISM; GROWTH-FACTOR-I; GENETIC-VARIATION; REGULATING GENES; STEROID-HORMONES; ASSOCIATION; PREDICTORS; ESTROGEN; DISEASE; LENGTH;
D O I
10.1210/jc.2009-1911
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Androgens are key regulators of prostate gland maintenance and prostate cancer growth, and androgen deprivation therapy has been the mainstay of treatment for advanced prostate cancer for many years. Along-standing hypothesis has been that inherited variation in the androgen receptor (AR) gene plays a role in prostate cancer initiation. However, studies to date have been inconclusive and often suffered from small sample sizes. Objective and Methods: We investigated the association of AR sequence variants with circulating sex hormone levels and prostate cancer risk in 6058 prostate cancer cases and 6725 controls of Caucasian origin within the Breast and Prostate Cancer Cohort Consortium. We genotyped a highly polymorphic CAG microsatellite in exon 1 and six haplotype tagging single nucleotide polymorphisms and tested each genetic variant for association with prostate cancer risk and with sex steroid levels. Results: We observed no association between AR genetic variants and prostate cancer risk. However, there was a strong association between longer CAG repeats and higher levels of testosterone (P = 4.73 x 10(-5)) and estradiol (P = 0.0002), although the amount of variance explained was small (0.4 and 0.7%, respectively). Conclusions: This study is the largest to date investigating AR sequence variants, sex steroid levels, and prostate cancer risk. Although we observed no association between AR sequence variants and prostate cancer risk, our results support earlier findings of a relation between the number of CAG repeats and circulating levels of testosterone and estradiol. (J Clin Endocrinol Metab 95: E121-E127, 2010)
引用
收藏
页码:E121 / E127
页数:7
相关论文
共 50 条
  • [1] Sequence variants of estrogen receptor β and risk of prostate cancer in the national cancer institute breast and prostate cancer cohort consortium
    Chen, Yen-Ching
    Kraft, Peter
    Bretsky, Philip
    Ketkar, Shamika
    Hunter, David J.
    Albanes, Demetrius
    Altshuler, David
    Andriole, Gerald
    Berg, Christine D.
    Boeing, Heiner
    Burtt, Noel
    Bueno-de-Mesquita, Bas
    Cann, Howard
    Canzian, Federico
    Chanock, Stephen
    Dunning, Alison
    Feigelson, Heather S.
    Freedman, Matthew
    Gaziano, J. Michael
    Giovannucci, Edward
    Sanchez, Maria-Jose
    Haiman, Christopher A.
    Hallmans, Goran
    Hayes, Richard B.
    Henderson, Brian E.
    Hirschhorn, Joel
    Kaaks, Rudolf
    Key, Timothy J.
    Kolonel, Laurence N.
    LeMarchand, Loic
    Ma, Jing
    Overvad, Kim
    Palli, Domenico
    Pharaoh, Paul
    Pike, Malcolm
    Riboli, Eliot
    Rodriguez, Carmen
    Setiawan, V. Wendy
    Stampfer, Meir
    Stram, Daniel O.
    Thomas, Gilles
    Thun, Michael J.
    Travis, Ruth C.
    Virtamo, Jarmo
    Trichopouiou, Antonia
    Wacholder, Sholom
    Weinstein, Stephanie J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (10) : 1973 - 1981
  • [2] Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
    Shui, Irene M.
    Lindstroem, Sara
    Kibel, Adam S.
    Berndt, Sonja I.
    Campa, Daniele
    Gerke, Travis
    Penney, Kathryn L.
    Albanes, Demetrius
    Berg, Christine
    Bueno-de-Mesquita, H. Bas
    Chanock, Stephen
    Crawford, E. David
    Diver, W. Ryan
    Gapstur, Susan M.
    Gaziano, J. Michael
    Giles, Graham G.
    Henderson, Brian
    Hoover, Robert
    Johansson, Mattias
    Le Marchand, Loic
    Ma, Jing
    Navarro, Carmen
    Overvad, Kim
    Schumacher, Fredrick R.
    Severi, Gianluca
    Siddiq, Afshan
    Stampfer, Meir
    Stevens, Victoria L.
    Travis, Ruth C.
    Trichopoulos, Dimitrios
    Vineis, Paolo
    Mucci, Lorelei A.
    Yeager, Meredith
    Giovannucci, Edward
    Kraft, Peter
    EUROPEAN UROLOGY, 2014, 65 (06) : 1069 - 1075
  • [3] Vitamin D Receptor Polymorphisms and Breast Cancer Risk: Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
    McKay, James D.
    McCullough, Marjorie L.
    Ziegler, Regina G.
    Kraft, Peter
    Saltzman, Barbara S.
    Riboli, Elio
    Barricarte, Aurelio
    Berg, Christine D.
    Bergland, Goran
    Bingham, Sheila
    Brustad, Magritt
    Bueno-de-Mesquita, H. Bas
    Burdette, Laurie
    Buring, Julie
    Calle, Eugenia E.
    Chanock, Stephen J.
    Clavel-Chapelon, Francoise
    Cox, David G.
    Dossus, Laure
    Feigelson, Heather Spencer
    Haiman, Christopher A.
    Hankinson, Susan E.
    Hoover, Robert N.
    Hunter, David J.
    Husing, Anika
    Kaaks, Rudolph
    Kolonel, Laurence N.
    Le Marchand, Loic
    Linseisen, Jakob
    McCarty, Catherine A.
    Overvad, Kim
    Panico, Salvatore
    Purdue, Mark P.
    Stram, Daniel O.
    Stevens, Victoria L.
    Trichopoulos, Dimitrios
    Willett, Walter C.
    Yuenger, Jeffrey
    Thun, Michael J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (01) : 297 - 305
  • [4] A comprehensive analysis of the androgen receptor gene and risk of breast cancer:: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
    Cox, David G.
    Blanche, Helene
    Pearce, Celeste L.
    Calle, Eugenia E.
    Colditz, Graham A.
    Pike, Malcolm C.
    Albanes, Demetrius
    Allen, Naomi E.
    Amiano, Pilar
    Berglund, Goran
    Boeing, Heiner
    Buring, Julie
    Burtt, Noel
    Canzian, Federico
    Chanock, Stephen
    Clavel-Chapelon, Francoise
    Feigelson, Heather Spencer
    Freedman, Matthew
    Haiman, Christopher A.
    Hankinson, Susan E.
    Henderson, Brian E.
    Hoover, Robert
    Hunter, David J.
    Kaaks, Rudolf
    Kolonel, Laurence
    Kraft, Peter
    LeMarchand, Loic
    Lund, Eiliv
    Palli, Domenico
    Peeters, Petra H. M.
    Riboli, Elio
    Stram, Daniel O.
    Thun, Michael
    Tjonneland, Anne
    Trichopoulos, Dimitrios
    Yeager, Meredith
    BREAST CANCER RESEARCH, 2006, 8 (05)
  • [5] A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
    David G Cox
    Hélène Blanché
    Celeste L Pearce
    Eugenia E Calle
    Graham A Colditz
    Malcolm C Pike
    Demetrius Albanes
    Naomi E Allen
    Pilar Amiano
    Goran Berglund
    Heiner Boeing
    Julie Buring
    Noel Burtt
    Federico Canzian
    Stephen Chanock
    Françoise Clavel-Chapelon
    Heather Spencer Feigelson
    Matthew Freedman
    Christopher A Haiman
    Susan E Hankinson
    Brian E Henderson
    Robert Hoover
    David J Hunter
    Rudolf Kaaks
    Laurence Kolonel
    Peter Kraft
    Loic LeMarchand
    Eiliv Lund
    Domenico Palli
    Petra HM Peeters
    Elio Riboli
    Daniel O Stram
    Michael Thun
    Anne Tjonneland
    Dimitrios Trichopoulos
    Meredith Yeager
    Breast Cancer Research, 8
  • [6] CYP17 genetic variation and risk of breast and prostate cancer from the national Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
    Setiawan, Veronica Wendy
    Schumacher, Fredrick R.
    Haiman, Christopher A.
    Stram, Daniel O.
    Albanes, Demetrius
    Altshuler, David
    Berglund, Gran
    Buring, Julie
    Calle, Eugenia E.
    Clavel-Chapelon, Françoise
    Cox, David G.
    Gaziano, J. Michael
    Hankinson, Susan E.
    Hayes, Richard B.
    Henderson, Brian E.
    Hirschhorn, Joel
    Hoover, Robert
    Hunter, David J.
    Kaaks, Rudolf
    Kolonel, Laurence N.
    Kraft, Peter
    Ma, Jing
    Le Marchand, Loic
    Linseisen, Jakob
    Lund, Eiliv
    Navarro, Carmen
    Overvad, Kim
    Palli, Domenico
    Peeters, Petra H. M.
    Pike, Malcolm C.
    Riboli, Elio
    Stampfer, Meir J.
    Thun, Michael J.
    Travis, Ruth
    Trichopoulos, Dimitrios
    Yeager, Meredith
    Ziegler, Regina G.
    Feigelson, Heather Spencer
    Chanock, Stephen J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (11) : 2237 - 2246
  • [7] Genetic Variation in the Vitamin D Pathway in Relation to Risk of Prostate Cancer-Results from the Breast and Prostate Cancer Cohort Consortium
    Mondul, Alison M.
    Shui, Irene M.
    Yu, Kai
    Travis, Ruth C.
    Stevens, Victoria L.
    Campa, Daniele
    Schumacher, Frederick R.
    Ziegler, Regina G.
    Bueno-de-Mesquita, H. Bas
    Berndt, Sonja
    Crawford, E. D.
    Gapstur, Susan M.
    Gaziano, J. Michael
    Giovannucci, Edward
    Haiman, Christopher A.
    Henderson, Brian E.
    Hunter, David J.
    Johansson, Mattias
    Key, Timothy J.
    Le Marchand, Loic
    Lindstroem, Sara
    McCullough, Marjorie L.
    Navarro, Carmen
    Overvad, Kim
    Palli, Domenico
    Purdue, Mark
    Stampfer, Meir J.
    Weinstein, Stephanie J.
    Willett, Walter C.
    Yeager, Meredith
    Chanock, Stephen J.
    Trichopoulos, Dimitrios
    Kolonel, Laurence N.
    Kraft, Peter
    Albanes, Demetrius
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (04) : 688 - 696
  • [8] CYP19A1 Genetic Variation in Relation to Prostate Cancer Risk and Circulating Sex Hormone Concentrations in Men from the Breast and Prostate Cancer Cohort Consortium
    Travis, Ruth C.
    Schumacher, Fredrick
    Hirschhorn, Joel N.
    Kraft, Peter
    Allen, Naomi E.
    Albanes, Demetrius
    Berglund, Goran
    Berndt, Sonja I.
    Boeing, Heiner
    Bueno-de-Mesquita, H. Bas
    Calle, Eugenia E.
    Chanock, Stephen
    Dunning, Alison M.
    Hayes, Richard
    Feigelson, Heather Spencer
    Gaziano, J. Michael
    Giovannucci, Edward
    Haiman, Christopher A.
    Henderson, Brian E.
    Kaaks, Rudolf
    Kolonel, Laurence N.
    Ma, Jing
    Rodriguez, Laudina
    Riboli, Elio
    Stampfer, Meir
    Stram, Daniel O.
    Thun, Michael J.
    Tjonneland, Anne
    Trichopoulos, Dimitrios
    Vineis, Paolo
    Virtamo, Jarmo
    Le Marchand, Loic
    Hunter, David J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (10) : 2734 - 2744
  • [9] Interactions Between Genetic Variants and Breast Cancer Risk Factors in the Breast and Prostate Cancer Cohort Consortium
    Campa, Daniele
    Kaaks, Rudolf
    Le Marchand, Loic
    Haiman, Christopher A.
    Travis, Ruth C.
    Berg, Christine D.
    Buring, Julie E.
    Chanock, Stephen J.
    Diver, W. Ryan
    Dostal, Lucie
    Fournier, Agnes
    Hankinson, Susan E.
    Henderson, Brian E.
    Hoover, Robert N.
    Isaacs, Claudine
    Johansson, Mattias
    Kolonel, Laurence N.
    Kraft, Peter
    Lee, I-Min
    McCarty, Catherine A.
    Overvad, Kim
    Panico, Salvatore
    Peeters, Petra H. M.
    Riboli, Elio
    Jose Sanchez, Maria
    Schumacher, Fredrick R.
    Skeie, Guri
    Stram, Daniel O.
    Thun, Michael J.
    Trichopoulos, Dimitrios
    Zhang, Shumin
    Ziegler, Regina G.
    Hunter, David J.
    Lindstroem, Sara
    Canzian, Federico
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (16): : 1252 - 1263
  • [10] Common Genetic Variants in Prostate Cancer Risk Prediction-Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
    Lindstroem, Sara
    Schumacher, Fredrick R.
    Cox, David
    Travis, Ruth C.
    Albanes, Demetrius
    Allen, Naomi E.
    Andriole, Gerald
    Berndt, Sonja I.
    Boeing, Heiner
    Bueno-de-Mesquita, H. Bas
    Crawford, E. David
    Diver, W. Ryan
    Gaziano, J. Michael
    Giles, Graham G.
    Giovannucci, Edward
    Gonzalez, Carlos A.
    Henderson, Brian
    Hunter, David J.
    Johansson, Mattias
    Kolonel, Laurence N.
    Ma, Jing
    Le Marchand, Loic
    Pala, Valeria
    Stampfer, Meir
    Stram, Daniel O.
    Thun, Michael J.
    Tjonneland, Anne
    Trichopoulos, Dimitrios
    Virtamo, Jarmo
    Weinstein, Stephanie J.
    Willett, Walter C.
    Yeager, Meredith
    Hayes, Richard B.
    Severi, Gianluca
    Haiman, Christopher A.
    Chanock, Stephen J.
    Kraft, Peter
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (03) : 437 - 444